Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.38% |
| 2 | Healthcare | 7.46% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.11% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1751
PUT
iShares Biotechnology ETF
IBB
$10.9B
| $12.5M | 0.01% |
98,400
-61,300
| -38% | -$7.96M |
|
1752
Banco Bilbao Vizcaya Argentaria
BBVA
$160B
| $12.5M | 0.01% |
1,626,655
+824,354
| +103% | +$5.9M |
|
|
X
1753
PUT
DELISTED
US Steel
X
| $12.5M | 0.01% |
499,100
+301,700
| +153% | +$7.02M |
|
1754
CALL
GSK
GSK
$104B
| $12.5M | 0.01% |
350,100
-8,700
| -2% | -$312K |
|
|
NFYS
1755
DELISTED
Enphys Acquisition Corp.
NFYS
| $12.5M | 0.01% |
1,200,000
| – | – |
|
1756
Weave Communications
WEAV
$583M
| $12.5M | 0.01% |
1,121,863
+1,033,867
| +1,175% | +$6.91M |
|
1757
PUT
Enphase Energy
ENPH
$4.94B
| $12.5M | 0.01% |
74,400
+63,300
| +570% | +$11.3M |
|
1758
PUT
SiriusXM
SIRI
$9.68B
| $12.5M | 0.01% |
275,000
+175,000
| +175% | +$6.61M |
|
1759
TaskUs
TASK
$730M
| $12.4M | 0.01% |
1,099,275
+1,084,275
| +7,229% | +$13.2M |
|
1760
Banco Macro
BMA
$4.97B
| $12.4M | 0.01% |
471,307
+367,361
| +353% | +$7.34M |
|
1761
iShares MSCI United Kingdom ETF
EWU
$3.88B
| $12.4M | 0.01% |
384,237
+122,248
| +47% | +$4.03M |
|
1762
Intercontinental Exchange
ICE
$90.8B
| $12.4M | 0.01% |
109,838
-684,688
| -86% | -$74.1M |
|
1763
Napco Security Technologies
NSSC
$1.3B
| $12.4M | 0.01% |
358,435
-69,504
| -16% | -$2.43M |
|
1764
CEMIG Preferred Shares
CIG
$5.78B
| $12.4M | 0.01% |
6,132,148
-25,320
| -0.4% | -$47.5K |
|
|
SCPH
1765
DELISTED
scPharmaceuticals
SCPH
| $12.4M | 0.01% |
1,216,206
-437,807
| -26% | -$4.57M |
|
1766
PUT
Alnylam Pharmaceuticals
ALNY
$32.1B
| $12.4M | 0.01% |
+65,200
| New | +$12.9M |
|
1767
CALL
Realty Income
O
$59.5B
| $12.4M | 0.01% |
207,000
-12,700
| -6% | -$775K |
|
1768
Domino's
DPZ
$11.6B
| $12.4M | 0.01% |
36,725
-29,950
| -45% | -$9.45M |
|
1769
Ocular Therapeutix
OCUL
$2.39B
| $12.4M | 0.01% |
2,396,840
+1,360,285
| +131% | +$8.09M |
|
|
PENG
1770
Penguin Solutions Inc
PENG
$2.58B
| $12.4M | 0.01% |
425,994
+234,311
| +122% | +$4.7M |
|
1771
PUT
Box
BOX
$4.57B
| $12.4M | 0.01% |
+420,600
| New | +$11.6M |
|
|
HCVI
1772
DELISTED
Hennessy Capital Investment Corp. VI Class A Common Stock
HCVI
| $12.3M | 0.01% |
1,203,462
| – | – |
|
1773
U-Haul Holding Co Series N
UHAL.B
$11.9B
| $12.3M | 0.01% |
242,897
+202,157
| +496% | +$10.6M |
|
1774
CALL
EQT Corp
EQT
$33.8B
| $12.3M | 0.01% |
299,200
+20,700
| +7% | +$732K |
|
|
INZY
1775
DELISTED
Inozyme Pharma
INZY
| $12.3M | 0.01% |
2,206,158
+515,083
| +30% | +$3.04M |
|
Similar funds
Israel Englander's Q2 2023 Portfolio in Review
As of Q2 2023, Israel Englander held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Israel Englander deployed $14B of net new capital in Q2 2023, opening 870 new positions and adding to 2,213 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, down from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Israel Englander's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Israel Englander added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Israel Englander's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Israel Englander fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Israel Englander's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Israel Englander opened 870 new positions and closed 1,192 in Q2 2023.
- Israel Englander's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.